Clinical Trials Browser

NCT04789486 2026-05-14

Nano-SMART: Nanoparticles With MR Guided SBRT in Centrally Located Lung Tumors and Pancreatic Cancer

Phase 1/2 Recruiting

100 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT06667908 2026-05-11

CONVERGE

Phase 2 Recruiting

130 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT06116786 2026-05-08

A Study of JNJ-86974680 in Participants With Advanced Non-small Cell Lung Cancer

Phase 1 Recruiting

126 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT02468024 2026-04-16

STABLE-MATES

Phase 3 Recruiting

272 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT06141070 2026-04-14

ANDROMEDA

Phase 3 Recruiting

240 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT06114108 2026-04-02

salVage

Phase NA Recruiting

128 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT04151940 2026-01-14

PET/CT Changes During Chemoimmunotherapy and Radiation Therapy in Patients With Stage IV Non-small Cell Lung Cancer

Phase NA Recruiting

80 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT07103395 2026-01-14

A Study Evaluating Neoadjuvant Chemotherapy, Concurrent Chemoradiotherapy Combined With Dual Immune Checkpoint Blockade in Patients With Locally Advanced Non-Small Cell Lung Cancer

Phase 2 Recruiting

56 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT07073365 2025-12-30

BOOST

Phase 2 Recruiting

70 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT04550104 2025-12-19

CONCORDE

Phase 1 Recruiting

200 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT06305715 2025-10-07

Radiation Prior to TKI to Delay Progression in Advanced Driver-Mutated Non-small Cell Lung Cancers (RadiaNCe Lung X)

Phase 2 Recruiting

34 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT07166003 2025-09-10

NeoIP-Lung

Recruiting

500 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT07014202 2025-07-30

Consolidation Radiotherapy vs. Observation in Oligoresidual Advanced Non-Small Cell Lung Cancer After Chemo-Immunotherapy

Phase 2 Recruiting

224 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT07086456 2025-07-25

Combination of Concurrent Chemoradiotherapy With Surufatinib and Tislelizumab in Patients With Locally Advanced Non-Small Cell Lung Cancer

Phase 2 Recruiting

80 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT06311981 2025-06-13

Carbon Ion Radiotherapy for Locally Advanced Lung Cancer in Elderly Patients

Phase 2 Recruiting

29 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung, Radiation Injuries

NCT06069570 2025-03-05

Safety Study for a Gamma Delta T Cell Product Used With Low Dose Radiotherapy in Patients With Locally Advanced or Metastatic NSCLC or Solid Tumors With Bone Metastases

Phase 1 Recruiting

48 enrolled

Thoracic

Carcinoma, Carcinoma, Non-Small-Cell Lung

NCT05468242 2024-10-30

Study of Tislelizumab for Locally Advanced Non-Small Cell Lung Cancer Following Neoadjuvant Chemotherapy Plus Tislelizumab ± Bevacizumab and Definitive Concurrent Chemoradiation Therapy

Phase 2 Recruiting

116 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT05501665 2024-10-17

Split Course Adaptive Radiation Therapy With Pembrolizumab With/Without Chemotherapy for Treating Stage IV Lung Cancer

Phase 1/2 Recruiting

25 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT05766800 2024-09-19

Induction Therapy With PD-1 Antibody Combined With Platinum-based Doublet Chemotherapy for Locally-advanced Non-small Cell Lung Cancer

Phase 2 Recruiting

100 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT05584267 2024-05-30

Immune Treatment of Brain Metastasis of Lung Cancer Combined With Large-segmentation Precision Radiotherapy

Phase 2 Recruiting

140 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung